Live Chat Software

The Only Forum to Map the Challenges of Pre-Approved Access Programmes from End-to-End

Early Access Programmes, Managed Access Programmes, Compassionate Use Programmes, Named Patient Programmes, Pre-Approval Programmes - while there may be different names, there are similar challenges.

With ever evolving regulations and the rising number of unsolicited requests from increasingly well informed patients, Pharma must be prepared for any eventuality. However, these obstacles can arise at any time during a Pre-Approved Access Programme, from the point of setting objectives in the early planning stages, to the strategic logistical decisions, or navigating the highly diverse European regulatory landscape through to offering Post-Trial Access Programmes and other operational challenges.  The Early and Managed Access Programmes Europe forum brings together over 70 industry leaders to share end-to-end, best practice strategies, to ensure you can fulfil your patients unmet medical needs.

Bringing together over 70 industry professionals, the Early and Managed Access Programmes forum provides a unique platform to enhance the end-to-end process of your Early Access Programme. Through open discussion and high levels of interactivity, this event provides an unrivalled opportunity to solve your challenges across the timeline of your Early Access Programme.


Download Agenda


2019 Speakers Include:

View All Speakers

What Will be Covered?

  • Navigate the highly diverse European regulatory landscape
  • Optimise your pre-approved access programme by streamlining your approach to clinical operations
  • Plan for success by setting clear objectives and developing your skills in cross-functional collaboration
  • View your pre-approved access programme as part of a continuum of development by effectively and compliantly collecting Real World Data
  • Safeguard your patient’s access to medicine by hearing best practice case studies in logistical strategy
  • Ensure your pre-approved access programme is truly patent- centric by discovering how to engage patients at each stage of the programme, from early planning to close out, and beyond

VIEW Agenda

Who is The Forum For?

  • SME and Big Pharma and Biotech, including:
    • - Clinical/Medical Operations
    • - Medical Affairs
    • - Regulatory Affairs
    • - Market Access
    • - Pharmacovigilance
  • Contact Research Organisations
  • Patient Advocates
  • MAP Providers
  • Logistics Providers
  • Regulatory Consultants

VIEW pricing

What is the industry saying about Pharma IQ's events?

Sponsors & Exhibitors
Media Partners